Head-to-head · WeighScore
Kin Meds vs NuviaRx
The verdict
NuviaRx takes it — 73.5/100 to 72.9/100, but only just.
NuviaRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuviaRx is a GLP-1 weight-loss telehealth service offering compounded semaglutide (from $140/mo) and tirzepatide (from $170/mo) with transparent pricing and free delivery. Kin Meds is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Kin Meds | NuviaRx |
|---|---|---|
| WeighScore | 72.9/100 | 73.5/100 |
| Grade | C | C |
| Scorecard rank | #73 | #69 |
| Semaglutide | $149/mo (brand Wegovy) | $140/mo (all doses, compounded) |
| Tirzepatide | $149/mo (brand Zepbound) | $170/mo (all doses, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #73 · C
Strengths
- Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
- Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
- LegitScript verified
- Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
- Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health
Where it loses points
- Legal entity name and state of incorporation not publicly disclosed
- The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
- Per-state availability not listed
- $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
- Lab work and dose-titration support not clearly described
Graded #69 · C
Strengths
- Transparent, affordable pricing — compounded semaglutide from $140/mo, tirzepatide from $170/mo
- Free delivery included; clinical evaluation and prescription bundled (if eligible)
- Full legal suite published (Terms, Privacy, HIPAA Notice, Informed Consent, Medical Disclaimer)
- Named operating entity (NuviaRx Health Inc.) with a US address and phone support
Where it loses points
- Compounding pharmacy partner not named ('partner pharmacy')
- Not LegitScript-certified (no certification displayed)
- Lowest pricing is 'as low as' — likely requires a longer prepaid plan
- State availability not published
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.